Summit Therapeutics Inc.

SMMTNASDAQHealthcare● Active

$14.77

$-0.07(-0.47%)

Market Cap$11.5B

P/E Ratio—

52W High$30.98

52W Low$13.83

Avg Volume4.1M

Open$15.23

Beta-1.31

Overview

Summit Therapeutics Inc. (SMMT) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

SMMT · net income · updated Jun 8, 2026

Core profitability metrics

SMMT · net income · margin · TTM · CAGR

Net income was −$1.08B for FY2025 (fiscal year ending 2025-12-31), down 510.7% year-over-year. Net profit margin was —. Based on available data, Summit Therapeutics Inc. has been profitable since at least 2019.

FY2025 Net Income−$1.08B▼ -510.7% YoY

Trailing 12M (TTM)−$1.05Btrailing 4 quarters sum

Net Profit Margin——

YoY Change-510.7%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 8, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %★ First Profit: 2019

▸ FMP /income-statement · Annual · SMMT net income history · SMMT profit margin

Annual net income data

SMMT · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2025Loss−$1.08B▼ 510.7%—$0

FY2024Loss−$176.8M▲ +63.4%—$0

FY2023Loss−$482.4M▼ 640.2%—$0

FY2022Loss−$65.2M▲ +0.5%-11174.8%$583,190

FY2021Loss−$65.5M▼ 70.0%-4897.8%$1.3M

Net income vs peers (Healthcare)

SMMT vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

Summit Therapeutics Inc.YOU

SMMT

−$1.08B-510.7%—

Loss

Eli Lilly and Company

LLY

$20.64B+94.9%31.7%

77%

UnitedHealth Group Incorporated

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Summit Therapeutics Inc. (SMMT) reported net income of −$1.08B for FY2025 (fiscal year ending 2025-12-31), down 510.7% year-over-year. The net profit margin was — — meaning the company kept $— of every dollar of revenue as profit.

Based on available data, Summit Therapeutics Inc. has been profitable since at least 2019. Net income reached a peak of $10.9M in FY2019. Data available for 15 fiscal years.

Summit Therapeutics Inc.'s net profit margin was — for FY2025, based on the latest annual results.

Investors sometimes search for "Summit Therapeutics Inc. net worth" — the company's market capitalization is a separate figure from SMMT net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

SMMT net income · 4 questions

Summit Therapeutics Inc. is not currently profitable on an annual basis. The company reported a net loss of $1.08B for FY2025.

is SMMT profitabledoes SMMT make a profitSMMT profitabilitySMMT profitable company

▸ Source: FMP /income-statement · GAAP · Summit Therapeutics Inc. · Summit Therapeutics Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026